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KI virus was detected in respiratory secretions of 8/367 
(2.2%) symptomatic and 0/96 asymptomatic children (p = 
0.215). WU virus was detected in 26/367 (7.1%) of symp-
tomatic children and 6/96 (6.3%) asymptomatic children (p 
= 1.00). These human polyomaviruses may not indepen-
dently cause respiratory tract disease in young children. 
I
n 2007, 2 new human polyomaviruses, KI virus (KIV) 
and WU virus (WUV), were identiﬁ   ed by molecular 
screening of respiratory secretions from children <2 years 
of age with symptomatic respiratory tract disease (1,2). 
Both viruses have since been detected in asymptomatic 
children and in those concurrently infected with other re-
spiratory viruses, suggesting that KIV and WUV may not 
cause respiratory tract disease (3–5). To further understand 
the epidemiology of these viruses in young children and to 
clarify their association with symptomatic respiratory tract 
infections in this age group, we screened respiratory speci-
mens from both asymptomatic and symptomatic children 
for the presence of KIV and WUV.
The Study
Respiratory specimens from 2 groups of children (all 
<2 years of age) were collected in 2004 and screened for 
KIV and WUV. The ﬁ  rst group comprised symptomatic 
children whose respiratory specimens were submitted to 
the Clinical Virology Laboratory, Yale–New Haven Hos-
pital, New Haven, Connecticut. These respiratory speci-
mens tested negative for respiratory syncytial virus (RSV), 
parainﬂ  uenza viruses (types 1–3), inﬂ  uenza viruses A and 
B, and adenovirus by direct ﬂ  uorescence antibody assay. 
The second group comprised asymptomatic children at 
the hospital-afﬁ  liated pediatric clinic for well-child care. 
Nucleic acids were extracted from each specimen by us-
ing QIAamp nucleic acid puriﬁ  cation kits (QIAGEN, Va-
lencia, CA, USA). Samples were screened by nested PCR 
for both KIV and WUV (for WUV, the ﬁ  rst primers were 
those used by Gaynor et. al., and the nested primers were 
5′-GCGCATCAAGAGGCACAGCTACTATTTC-3′ and 
5′-GCGCCTAGCCTGTGAACTCCATC-3′). The G/C 
clamp for each primer is underlined. (1,2). Positive and 
negative controls were included in each set of PCRs. All 
PCR products were sequenced. Any child who had multiple 
specimens with positive results was included once in the 
total number of children whose specimens tested positive 
for a given virus. 
Specimens from symptomatic children who tested 
positive for KIV or WUV were also screened for human 
bocavirus (HBoV); human metapneumovirus (hMPV); 
human coronaviruses (HCoV) 229E, NL63, and HKU1; 
and human picornaviruses (including rhinoviruses [HRV]) 
by using previously described methods (6–12). To screen 
for human parainﬂ  uenzavirus type 4 and HCoV OC43, 
RNA extraction and reverse transcription were performed 
as previously described (7). The primers used to amplify 
hPIV4 were 5′-GCGAGAGGATCCAGCTGGTGGC-3′ 
and 5′-GCGCCCTAATCTTTCCTGTTGATGG-3′. The 
primers for HCoV-OC43 were 5′-GCATAAGCCCC
GCCAGAAGAGGAG-3′ and 5′-GCGCTGACGCTGTG
GTTTTGGACT-3′. 
We tested 423 direct ﬂ  uorescent  antibody–negative 
respiratory specimens, from 367 children, for KIV and 
WUV. The results of screening are summarized in the 
Table. Of the 367 symptomatic children, there were 8 
(2.2%; 95% conﬁ  dence interval [CI] 1.0%–4.3%) whose 
specimens tested positive for KIV and 26 (7.1%; 95% CI 
4.7%–10.2%) whose specimens tested positive for WUV. 
One child had 2 specimens that tested positive for WUV. 
None (0%; 95% CI 0%–4.0%) of the 96 specimens from 
asymptomatic children tested positive for KIV. Specimens 
from six (6.3%; 95% CI 2.3%–13.1%) of the 96 asymp-
tomatic children tested positive for WUV. The odds ratio 
for the proportions of symptomatic and asymptomatic chil-
dren positive for WUV was 1.14 (95% CI 0.46–2.86; p = 
1.0, Fisher exact test). The odds ratio for the proportions of 
symptomatic and asymptomatic children positive for KIV 
is undeﬁ  ned (none of the specimens from children in the 
asymptomatic group tested positive). The difference was 
not statistically signiﬁ  cant (p = 0.215). The distribution of 
number of samples screened per month was similar for the 
asymptomatic and symptomatic groups.
The monthly distribution of children positive for 
KIV or WUV is shown in Figure 1. The age distribution 
of KIV- and WUV-positive children is shown in Figure 2. 
The youngest KIV-positive child was 4 months of age. The 
youngest WUV-positive child was 12 days of age.
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Viral co-infection was detected in 2 (25%) of the 8 
KIV-positive specimens; 1 specimen tested positive for 
both HBoV and hMPV, and the other tested positive for 
HBoV. Of the 6 KIV-positive children whose specimens 
tested negative for other respiratory viruses, all had evi-
dence of respiratory tract disease or fever. Five (63%) of 
the KIV-positive children had underlying illnesses.
Viral co-infection was detected in 13 (50%) of the 26 
WUV-positive symptomatic children; 7 (26%) were posi-
tive for hMPV, 4 (15%) for HRV, 2 (7%) for HCoV-NL63, 
and 2 (7%) for HBoV. Two WUV-positive specimens test-
ed positive for both hMPV and HBoV. Of the 13 WUV-
positive children whose specimens tested negative for the 
other respiratory viruses, 12 had records available for re-
view. Nine (69%) had evidence of respiratory tract disease, 
including fever. Two of these children had potential nonin-
fectious explanations for their symptoms. One female child 
had end-stage pulmonary hypertension, and it was unclear 
whether her respiratory distress was due to worsening pul-
monary hypertension or an infectious process. Respiratory 
distress developed in a male child after suspected aspira-
tion; his symptoms resolved within 6 hours. 
Three of the WUV-positive children had been hospi-
talized since birth; specimens from 1 of these children test-
ed positive for WUV on 2 occasions. The interval between 
the ﬁ  rst and second specimen was 98 days, and during that 
time 3 other specimens from this child tested negative for 
WUV. The child was hospitalized throughout this period 
and received mechanical ventilation for chronic lung dis-
ease. This child and 2 others were hospitalized in the same 
respiratory care unit at the time of WUV detection. Another 
child whose specimens tested positive for WUV had re-
cently been discharged from that respiratory care unit.
Of 25 WUV-positive children whose records were 
available for review, 11 (44%) had underlying illnesses. Of 
the 6 asymptomatic children whose specimens tested posi-
tive for WUV, 1 had a history of prematurity and the other 
5 had no underlying illnesses.
Conclusions
We detected KIV and WUV in respiratory samples 
obtained from children in Connecticut in 2004. The rates 
of detection for the symptomatic children in our study 
are similar to those observed in prior studies (1,3,4). As 
in studies by others, we detected WUV in asymptomatic 
and symptomatic children (3–5,13). This ﬁ  nding provides 
further evidence that asymptomatic infection of WUV may 
occur. KIV was not detected in any of the asymptomatic 
children we tested. However, it is possible that subclinical 
infection with KIV occurs and that we failed to detect any 
cases because of the low prevalence of KIV in our study 
population. Our study had only 15% power to detect a dif-
ference between 2.2% and 0% for KIV, whereas it had ad-
equate power (90%) to detect a difference between 7.1% 
and 0% for WUV.
Co-infection with other respiratory viruses was a com-
mon ﬁ  nding in both KIV- and WUV-positive children. Be-
cause specimens from symptomatic children were tested for 
common viruses by antigen testing rather than PCR, which 
is presumably more sensitive, the co-infection rate could, 
in fact, be greater. The high rates of co-infection observed 
in our study and the studies of others support the notion 
that KIV and WUV may not cause respiratory tract disease. 
However, KIV or WUV was the only virus detected for a 
small number of children with evidence of respiratory tract 
disease, so it is still possible that these viruses contribute to 
respiratory tract disease in susceptible children. 
Detection of WUV in 3 patients hospitalized since 
birth suggests the potential for nosocomial, congenital, or 
perinatal infection. One of these children had 2 respiratory 
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Table. Detection of KIV and WUV in children <2 years of age with and without respiratory tract disease* 
Patient group  No. KIV-positive children/total no. tested (%)
No. WUV-positive children/total no. tested 
(%)
Respiratory tract disease  8/367 (2.2)†  26/367 (7.1)‡ 
Asymptomatic  0/96 (0)  6/96 (6.3) 
*KIV, KI virus; WUV, WU virus. 
†p = 0.215, compared with asymptomatic children. 
‡p = 1.0, compared with asymptomatic children. 
Figure 1. Monthly distribution of children positive for KI virus (KIV) 
and WU virus (WUV). The WUV-positive children include both 
asymptomatic and symptomatic children whose specimens tested 
positive for WUV. One child who tested positive for WUV in February 
and March is represented in both months. The superimposed line 
graph represents the number of children tested in each month.
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No. testedspecimens positive for WUV. Le et al. recently reported 
detection of WUV in multiple samples obtained from 2 im-
munocompromised patients (13). This ﬁ  nding may repre-
sent persistent or latent infection.
In conclusion, we have established that 2 recently 
discovered polyomaviruses, KIV and WUV, are circulat-
ing in Connecticut. Because of the high rates of viral co-
infection and detection of WUV in both asymptomatic and 
symptomatic children, these viruses may not be respiratory 
pathogens. 
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Figure 2. Age distribution of children positive for KI virus (KIV) 
and WU virus (WUV). The WUV-positive children include both 
asymptomatic and symptomatic children. One child whose 
specimens tested positive at age 6 months and again at age 9 
months is represented in both age groups. The superimposed line 
graph represents the number of children tested in each age group.